FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention relates to pharmaceutical compositions based on indomethacin menthyl ester, which can be used as anti-inflammatory agents for the treatment of acute and chronic inflammatory diseases.
EFFECT: pharmaceutical compositions have anti-inflammatory, analgesic and antipyretic effects and are distinguished by the absence of adverse ulcerogenic effects in therapeutic doses.
1 cl, 7 tbl, 13 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NEW BIOLOGICALLY ACTIVE COMPOUND N-[3-(4-NITROPHENYLAMINO)-INDOL-2-YLMETHYLENE]AMINOGUANIDINE HYDROCHLORIDE WITH ANTIINFLAMMATORY ACTIVITY | 2010 |
|
RU2478618C2 |
| NONSTEROID ANTI-INFLAMMATORY ANALGESIC DRUG | 2005 |
|
RU2303450C2 |
| PHARMACEUTICAL COMPOSITION WITH ANTI-INFLAMMATORY, CARDIO- AND CHONDROPROTECTIVE ACTIVITY, ACTION PREVENTING GASTROPATHIES CAUSED BY NSAID, AND METHOD FOR PREPARING IT | 2011 |
|
RU2502507C2 |
| PREPARATION, POSSESSING GASTROPROTECTIVE ACTIVITY | 2014 |
|
RU2536225C1 |
| PHARMACEUTICAL COMPOSITION OF INDOMETACIN INCLUDED IN PHOSPHOLIPID NANOPARTICLES FOR TREATING RHEUMATIC AND INFLAMMATORY DISEASES | 2009 |
|
RU2417079C1 |
| BENZYLURSONATE - ANTI-INFLAMMATORY AND HEPATOPROTECTIVE AGENT | 2010 |
|
RU2430106C1 |
| AGENT POSSESSING ANTI-INFLAMMATORY ACTIVITY | 2004 |
|
RU2266748C1 |
| ANALGETIC, ANTIPYRETIC AND ANTI-INFLAMMATORY AGENT "PENTABUFEN" | 2002 |
|
RU2222322C1 |
| COMPOSITION FOR TREATMENT OF INFLAMMATORY DISEASE | 2005 |
|
RU2292917C1 |
| 3-[3-(MORPHOLINE-4-YL)PROPYL]-2-[(2,2,3-TRIMETHYLCYCLOPENT-3-ENE-1-YL)METHYL-1,3-THIAZOLIDINE-4-ONE WITH ANTI-ULCER AND ANTI-INFLAMMATORY ACTIVITY | 2017 |
|
RU2643669C1 |
